The Valley Desk

NCT01275222 · Interventional trial

Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors

Overall registry status Completed

Phase 1 · Phase 2

Conditions Gastrointestinal Stromal Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov